The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
Y Wang, H Chen, J Chen, M Han, JD Hu, J Hu… - Cancer Letters, 2018 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important curative
therapy for patients with leukemia. However, relapse remains the leading cause of death …
therapy for patients with leukemia. However, relapse remains the leading cause of death …
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
MM Berrien-Elliott, JA Foltz… - Science translational …, 2022 - science.org
Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce
cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK …
cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK …
Optimization of donor lymphocyte infusion for AML relapse after allo-HCT in the era of new drugs and cell engineering
Y Ye, L Yang, X Yuan, H Huang, Y Luo - Frontiers in Oncology, 2022 - frontiersin.org
Donor lymphocyte infusion (DLI) is a key strategy for the treatment of AML relapse after
allogeneic hematopoietic cell transplantation (allo-HCT) and has been used for either …
allogeneic hematopoietic cell transplantation (allo-HCT) and has been used for either …
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
C Schmid, M Labopin, N Schaap, H Veelken… - Bone marrow …, 2022 - nature.com
We report on 318 patients with acute leukemia, receiving donor lymphocyte infusion (DLI) in
complete hematologic remission (CHR) after allogeneic stem cell transplantation (alloSCT) …
complete hematologic remission (CHR) after allogeneic stem cell transplantation (alloSCT) …
[HTML][HTML] Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation
The curative potential of allogeneic hematopoietic cell transplantation (allo-HCT) in the
treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) …
treatment of acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) …
How I treat high-risk acute myeloid leukemia using preemptive adoptive cellular immunotherapy
A Biederstädt, K Rezvani - Blood, 2023 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a potentially curative
treatment for patients with high-risk acute leukemias, but unfortunately disease recurrence …
treatment for patients with high-risk acute leukemias, but unfortunately disease recurrence …
Graft engineering and adoptive immunotherapy: new approaches to promote immune tolerance after hematopoietic stem cell transplantation
A Bertaina, MG Roncarolo - Frontiers in immunology, 2019 - frontiersin.org
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapeutic option
for a wide range of immune and hematologic malignant and non-malignant disorders. Once …
for a wide range of immune and hematologic malignant and non-malignant disorders. Once …
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
N Santoro, JE Mooyaart, R Devillier, Y Koc… - Bone Marrow …, 2023 - nature.com
Donor lymphocyte infusion (DLI) is a treatment option to prevent or treat relapse after
allogeneic hematopoietic cell transplantation (HCT). We here report data for 173 patients …
allogeneic hematopoietic cell transplantation (HCT). We here report data for 173 patients …
[HTML][HTML] Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of …
Donor lymphocyte infusion has been used in the management of relapsed hematologic
malignancies after allogeneic hematopoietic cell transplantation. It can eradicate minimal …
malignancies after allogeneic hematopoietic cell transplantation. It can eradicate minimal …
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a …
G Battipaglia, A Boumendil, M Labopin… - Bone marrow …, 2019 - nature.com
Refractory or relapsed acute myeloid leukemia (R/R-AML) has poor prognosis. Allogeneic
hematopoietic stem-cell transplantation (HSCT) may provide cure in this scenario. We …
hematopoietic stem-cell transplantation (HSCT) may provide cure in this scenario. We …